Dr. George Dagliyan on the Economics of Technology Adoption
Published: 2026-02-10 — Dr. George Dagliyan site editorial team. Editorial brief.
Cost is one of the most powerful inhibitors of adoption. This commentary examines how organizations should think about the economics of new technology.
This is site editorial commentary about research themes associated with Dr. George Dagliyan. Interpretations and examples are not verified quotations, personal advice, or reports of client work. This material is general information, not medical, legal, or other professional advice.
Cost is more than the purchase price
This commentary points out that the visible price of a technology is rarely the real cost. Integration, training, change management, and ongoing governance all add up — and each is an inhibitor if it is underestimated.
Budgets built only around licensing tend to run into the hidden costs of adoption later, when they are hardest to absorb.
Value as the counterweight to cost
In the Dagliyan Theory, perceived value is a central facilitator. This commentary argues that the economic case for adoption rests on credibly demonstrating value early, so that facilitators can outweigh the inevitable cost inhibitors.
Time-to-value, more than total spend, often determines whether an initiative sustains support.
Sequencing investment to manage risk
Rather than committing everything at once, this commentary favors staged investment that ties further spending to demonstrated adoption. This keeps cost inhibitors proportionate to proven value and reduces the risk of large, stranded commitments.
Frequently Asked Questions
How does this commentary view the cost of new technology?
This commentary treats cost as a major adoption inhibitor that extends well beyond purchase price to integration, training, and governance, and recommends demonstrating value early and sequencing investment to keep cost proportionate to proven adoption.